Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 4:43 PM ET


Company Overview of Colorcon, Inc.

Company Overview

Colorcon, Inc. provides a range of pharmaceutical film coatings and pharmaceutical formulation development assistance. The company provides film coatings, excipients, polymers for controlled release, nutritional coatings, and printing inks, as well as food colorants, glazes and polishes, and confectionary inks. It serves pharmaceutical and nutritional supplement customers. The company was founded in 1961 and is based in Harleysville, Pennsylvania with locations in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Colorcon, Inc. operates as a subsidiary of BPSI Holdings Inc.

275 Ruth Road

Harleysville, PA 19438

United States

Founded in 1961





Key Executives for Colorcon, Inc.

Chief Executive Officer
Global Communication Director
General Manager for Formulation Technologies
Compensation as of Fiscal Year 2015.

Colorcon, Inc. Key Developments

Colorcon Opens Laboratory in China to Meet Demand for Rapid Pharmaceutical Formulation Development

Colorcon has set up a new technical service laboratory in Beijing, its second in China, which will focus on solid-dose development. The laboratory will provide support for the rapid development and commercialization of pharmaceutical drug formulations for customers from initial product concept to production and registration. The new laboratory is in line with Colorcon's strategy of expanding its presence in Asia, and will be located close to the clients who require rapid service in research and development as well as production scale-up. The laboratory will also focus on the manufacture of film coatings.

Colorcon, Inc. Introduces Opadry amb II

Colorcon announced a significant advancement in protection for pharmaceutical products sensitive to environmental moisture conditions with the introduction of Opadry amb II, a fully formulated high performance moisture barrier film coating. This unique formula provides best-in-class moisture protection and manufacturing productivity. Pigmented and clear options are available, all resulting in tablets with a glossy finish and well-defined logos without impacting dissolution. Opadry amb II is a fully formulated high performance moisture barrier film coating. This unique formula provides best-in-class moisture protection and manufacturing productivity.

Colorcon and BASF Cooperate on Kollicoat(R) IR for Ready-To-Use Pharmaceutical Coating Solutions

Colorcon, Inc. and BASF announced their cooperation for using immediate release coating polymer Kollicoat(R) IR for Colorcon's fully formulated ready-to-use coatings. Colorcon will expand their PVA-based product portfolio by offering customers an alternative efficient and convenient solution for the immediate release coating of pharmaceuticals and dietary supplements. "With this new ready-to-use coating option formulators can benefit from both the coating performance of Kollicoat IR and Colorcon's worldwide unique, customized services", said Daniele Piergentili, Vice President Global Marketing Pharma Ingredients at BASF. Adding Kollicoat IR as an alternative for use in targeted Opadry(R) complete film coating systems expands the cooperation between Colorcon and BASF. Kollicoat IR, an ethylene glycol and vinyl alcohol graft copolymer, is BASF's highly versatile and safe-in-use instant release coating polymer. This polymer enables processing at low temperatures and high solids content while delivering appropriate coating results. Kollicoat is monographed in all major markets, and has furthermore received GRAS status (Generally Regarded As Safe) in the US and the European E-Number (E1209) for application in dietary - nutritional supplements.

Similar Private Companies By Industry

Company Name Region
Makefield Therapeutics Inc. United States
Aeris Therapeutics, Inc. United States
RFI Extracts United States
Actient Pharmaceuticals, LLC United States
Janssen Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

January 18, 2016
Paulaur Corporation, Pharmaceutical Sugar Spheres Product Line

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Colorcon, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at